| Jason E Christensen, DO | |
|
36000 Darnall Loop Box 31, Fort Hood, TX 76544-4752 | |
| (254) 288-8303 | |
| (254) 286-7055 |
| Full Name | Jason E Christensen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 36000 Darnall Loop Box 31, Fort Hood, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083752174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | M0380 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gila Health Resources | 1254327216 | 9 |
News Archive
In the study, published in Development and Psychopathology, children reported to have chronic health problems showed higher rates of mental illness at 10 years, and those health problems continued to be associated with poor mental health at the ages of 13 and 15.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.
Underlining the key role of genomic surveillance in keeping tabs on the spread of SARS-CoV-2, a new medRxiv* preprint shows how a new variant called B.1.1.318 rose to dominance in the small island country of Mauritius, in the Indian Ocean.
› Verified 8 days ago
| Entity Name | Chandler Emergency Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104871961 PECOS PAC ID: 1658272968 Enrollment ID: O20040120000160 |
News Archive
In the study, published in Development and Psychopathology, children reported to have chronic health problems showed higher rates of mental illness at 10 years, and those health problems continued to be associated with poor mental health at the ages of 13 and 15.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.
Underlining the key role of genomic surveillance in keeping tabs on the spread of SARS-CoV-2, a new medRxiv* preprint shows how a new variant called B.1.1.318 rose to dominance in the small island country of Mauritius, in the Indian Ocean.
› Verified 8 days ago
| Entity Name | Gila Health Resources |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497740187 PECOS PAC ID: 1254327216 Enrollment ID: O20040423000876 |
News Archive
In the study, published in Development and Psychopathology, children reported to have chronic health problems showed higher rates of mental illness at 10 years, and those health problems continued to be associated with poor mental health at the ages of 13 and 15.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.
Underlining the key role of genomic surveillance in keeping tabs on the spread of SARS-CoV-2, a new medRxiv* preprint shows how a new variant called B.1.1.318 rose to dominance in the small island country of Mauritius, in the Indian Ocean.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason E Christensen, DO 36000 Darnall Loop Box 31, Fort Hood, TX 76544-4752 Ph: (254) 288-8303 | Jason E Christensen, DO 36000 Darnall Loop Box 31, Fort Hood, TX 76544-4752 Ph: (254) 288-8303 |
News Archive
In the study, published in Development and Psychopathology, children reported to have chronic health problems showed higher rates of mental illness at 10 years, and those health problems continued to be associated with poor mental health at the ages of 13 and 15.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.
Underlining the key role of genomic surveillance in keeping tabs on the spread of SARS-CoV-2, a new medRxiv* preprint shows how a new variant called B.1.1.318 rose to dominance in the small island country of Mauritius, in the Indian Ocean.
› Verified 8 days ago
Danielle Marie Pesce, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Dem Box 31, Fort Hood, TX 76544 Phone: 254-288-8303 Fax: 254-286-7055 | |
Dr. Derek R Linklater, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-493-4472 Fax: 512-710-1314 | |
Dr. Anthony Joseph Hackett, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 36000 Darnall Loop, Carl R. Darnall Amc, Fort Hood, TX 76544 Phone: 774-232-7090 | |
Hugh Merrigan Hiller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-553-4614 | |
Ryan Derrah, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 503-539-6893 | |
Sammy Taha, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 36065 Santa Fe Ave, Attn: Residency Center, Er Box 276, Fort Hood, TX 76544 Phone: 254-553-4614 |